U.S. High Throughput Screening Market Size & Outlook

Name: U.S. High Throughput Screening Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The high throughput screening market in the United States is expected to reach a projected revenue of US$ 19,789.5 million by 2033. A compound annual growth rate of 7.7% is expected of the United States high throughput screening market from 2026 to 2033.

Clinical Diagnostics
- Genetic Testing
  - High Throughput Screening Market Outlook

U.S. high throughput screening application outlook (Revenue, USD million, 2021-2033)
- Drug discovery programs
- Chemical biology programs
- Biochemical screening
- Cell- & organ-based screening
U.S. high throughput screening technology outlook (Revenue, USD million, 2021-2033)
- Cell Based Assays
  - Fluorometric Imaging Plate Reader Assays
    - Clinical applications (Cardiotoxicity assays)
    - In-vitro studies (Pharmacophores identification in drug discovery)
  - Reporter based Assays
    - Clinical applications (Reporter assay in biological systems analysis)
    - In-vitro studies (Genetic reporter assays in cloning tools for live-cell work)
- 3D - Cell Cultures
  - Clinical applications (Regenerative medicine)
  - In-vitro studies (Drug discovery, Molecular cell biology)
- Ultra High Throughput Screening

U.S. High Throughput Screening Market Size & Outlook

Data Tree

Sign up - it's easy, and free!